RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL

Catalog number BNC942662-100

Price for BNC942662-100

Size / count 1x 100 µL

About this product

The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney. Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC942662-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: Cadherin family member 12 (CDHF12) ; Cadherin related family member 16 (CDHR16) ; ELKS; HSCR1; Hydroxyaryl protein kinase; MEN2A; MEN2B; MTC1; Multiple endocrine neoplasia and medullary thyroid carcinoma 1; Oncogene RET; Proto-oncogene c-Ret; Proto-oncogene tyrosine-protein kinase receptor ret; PTC; RET; RET ELE1; RET51; RET9
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: RET
Gene ID: 5979
NCBI Gene ID: 350321
UniProt: P07949
Swiss Prot: P07949
Host: Mouse
Species Reactivity: Human
Reactivity: RET Proto-oncogene
Immunogen: Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)
Target Antigen: RET Proto-oncogene
Clonality: Monoclonal
Clone: RET/2662
Type: Primary
Source: Animal
Origin: Animal
Positive Control: Breast, Prostate or Colon Carcinoma.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 150 kDa (precursor) ; 170 kDa (Mature)
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG2b, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF594

Frequently Asked Questions

What is the catalog number for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL?

The catalog number for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL is BNC942662-100.

What sizes are available for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL?

RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL in stock?

RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL?

RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL?

Estimated delivery time for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL?

The safety data sheet for RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is RET Proto-oncogene (RET/2662), CF594 conjugate, 0.1mg/mL used for?

Is this product tested for endotoxin levels?

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Can I request additional validation data, such as western blot images, for this product?

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.